Sox9 is required for prostate development and prostate cancer initiation
about
Tbx18 Regulates the Differentiation of Periductal Smooth Muscle Stroma and the Maintenance of Epithelial Integrity in the ProstateTargeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and TreatmentAndrogen receptor functions in prostate cancer development and progressionMolecular pathways and targets in prostate cancerThe biology of castration-resistant prostate cancerSOX9, a potential tumor suppressor in cervical cancer, transactivates p21WAF1/CIP1 and suppresses cervical tumor growth.ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancerA far-upstream (-70 kb) enhancer mediates Sox9 auto-regulation in somatic tissues during development and adult regeneration.Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axisGene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors.Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signalingUpregulation of SOX9 in osteosarcoma and its association with tumor progression and patients' prognosisTrFAST: a tool to predict signaling pathway-specific transcription factor binding sites.Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer.Androgen receptor epigenetics.SOX9 drives WNT pathway activation in prostate cancer.Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations.Morphoregulatory pathways in prostate ductal development.Small molecule-induced mitochondrial disruption directs prostate cancer inhibition via UPR signalingTumorigenic potential of circulating prostate tumor cells.Budding process during the organogenesis of the ventral prostatic lobe in Mongolian gerbil.Prostate organogenesis: tissue induction, hormonal regulation and cell type specification.Immunohistochemical staining of ERG and SOX9 as potential biomarkers of docetaxel response in patients with metastatic castration-resistant prostate cancer.Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer.Negative regulation of the androgen receptor gene through a primate-specific androgen response element present in the 5' UTR.SOX9 is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition.Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and β-catenin.Perinatal exposure to mixtures of anti-androgenic chemicals causes proliferative lesions in rat prostate.miR-204 Shifts the Epithelial to Mesenchymal Transition in Concert with the Transcription Factors RUNX2, ETS1, and cMYB in Prostate Cancer Cell Line Model
P2860
Q27312119-44331018-F8F9-4063-A426-F0FF151178E5Q28076462-1F1BF77A-1C58-4908-BF0B-949F98E5B1EFQ33922393-F9F7FDEB-C818-4C09-B214-C93B76E9AA2BQ34365632-1B437FCB-E1A4-4D5B-BC10-B6F368C1FAAEQ35039889-B8BF9166-916B-4FBD-B5F4-9F14DA58CD01Q36299791-996B72C2-DD48-4EFA-982C-B0A1CD29C6F7Q36638207-87A1CF1A-5B07-43E3-B3C5-750B3AD4A90DQ36783626-457803BB-B1E7-4FE4-A765-87521EFF393DQ36961208-B078DE09-EC8A-425B-A21C-2E19ECB43355Q37124560-F64D274C-A03B-46B4-BE51-DAE0FD906E53Q37301823-68C6099D-36FE-4EFA-8DFA-85A599BD17BEQ37311518-52FCDC29-02A7-4723-8F17-0C7AFB484592Q37319943-E937EA3D-0BB4-4BA8-99E7-559D724A75B8Q37537822-CB47B210-E85D-48C0-9F92-D98464BA48DFQ38314940-2014B5A1-840F-4539-B0FD-16F7AC490426Q38780862-6843AE7E-FA5C-40D6-A421-926C441635A7Q38997020-027DC325-0CC1-49F8-B487-13A67DCEC723Q39018865-59FBA16F-0E24-4F9D-A4A5-318203CB4C94Q39117495-3931CF51-549F-4BA7-A19D-1C62D1ABE060Q39175526-7B48593E-740A-4C9B-8609-F44B13124698Q39205990-90F5ADFE-5636-4737-AEB1-EEB52DD3ADEEQ39235902-765892E4-9876-4C93-BDEE-AF84FE0A872AQ41839242-7B6D709C-5DF3-49B1-943E-3486BD9B3D1FQ42335698-F3AEEA10-F8A7-4C2C-A536-E5C468AEF2E0Q42878519-6F182C85-EC0A-435A-9199-0503A203C0D7Q50284819-AE53D5F0-4D79-4ED5-B6C0-F2C9EB345467Q52585710-EE258CB7-B6D8-4A65-8092-016D25BC2C34Q52654472-DD8D0E28-86CF-4A7B-8429-F5EC06653E53Q59051976-02CEAE4E-1395-4B58-99EC-AB51E6B606DC
P2860
Sox9 is required for prostate development and prostate cancer initiation
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Sox9 is required for prostate development and prostate cancer initiation
@ast
Sox9 is required for prostate development and prostate cancer initiation
@en
type
label
Sox9 is required for prostate development and prostate cancer initiation
@ast
Sox9 is required for prostate development and prostate cancer initiation
@en
prefLabel
Sox9 is required for prostate development and prostate cancer initiation
@ast
Sox9 is required for prostate development and prostate cancer initiation
@en
P2093
P2860
P356
P1433
P1476
Sox9 is required for prostate development and prostate cancer initiation
@en
P2093
Brian W Simons
David M Berman
Luigi Marchionni
Paula J Hurley
Zhenhua Huang
P2860
P304
P356
10.18632/ONCOTARGET.531
P407
P577
2012-06-01T00:00:00Z